LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Corgenix公司的埃博拉诊断检验研究荣获文摘奖

By LabMedica International staff writers
Posted on 11 Sep 2014
Print article
AACC重症检验与床旁检验分部的年会最佳文摘奖是为了表彰提交给AACC年会的杰出的科研论文文摘和展板论文。

Corgenix医疗用品公司(Broomfield, CO, USA)的埃博拉研究和拉沙热口述摘要因高质量的展板论文文摘“检测埃博拉和苏丹病毒的床旁诊断产品”而荣获该奖项。Corgenix公司总裁道格拉斯•辛普森评论说:“我们很高兴接受这一崇高的奖项,我们还必须感谢病毒性出血热联盟(VHFC)的学术界和产业界的合作伙伴,有了他们的帮助我们才有可能得奖。我们将继续努力开发突破性的诊断产品,检测埃博拉病毒、拉沙热病毒及其它微生物。快速、准确地检验困难环境中的这些微生物对于全球公共卫生和抵御生物恐怖威胁至关重要。”

美国国家卫生研究所(NIH)最近拨给Corgenix公司和VHFC一笔290万美元的经费,为期三年,以资助埃博拉快速诊断检验试剂盒的研制工作。Corgenix公司和VHFC已经开发出针对拉沙热病毒的ReLASV快速诊断检验, 且已获得CE标志。

现在西非爆发的埃博拉创下最大规模的纪录。辛普森先生说,将来必定需要护理点(POC)检验来快速鉴定和治疗病毒性出血热,包括拉沙热、埃博拉和马尔堡病。

Corgenix公司还宣读了一份口述摘要,题为“疑似拉沙热病例的预后:与塞拉利昂非发热人群之比较”。拉沙热与疟疾等其它疾病很难区分,该研究的目的是更好地识别和治疗拉沙热患者。Corgenix公司的法规与临床事务专家Bethany Belote宣读了研究结果,研究论文将发表于10月号的《临床化学》(Clinical Chemistry)杂志。

Related Links:
Corgenix医疗用品公司 
国家卫生研究所


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more